Sheer Richard, Schwab Phil, Essex Margaret Noyes, Cappelleri Joseph C, Reiners Andrew, Bobula Joel, Pasquale Margaret K
Comprehensive Health Insights, Inc, Humana Inc, 515 W. Market Street, Louisville, KY, 40202, USA.
Pfizer Inc, New York, NY, USA.
Drugs Aging. 2018 Oct;35(10):937-950. doi: 10.1007/s40266-018-0585-8.
Research to date on sprains, strains, and contusions has focused mainly on the analysis of sports-related injuries, occupational injuries, injuries resulting from automobile accidents, and severe injuries that result in inpatient hospital stays. Little is known about real-world acute sprains, strains, and contusions in an aging population. Patients may be treated with over-the-counter, oral, non-steroidal anti-inflammatory drugs (NSAIDs) for acute sprains, strains, and contusions or may require the use of prescription NSAIDs. For sprains, strains, and contusions treated with prescription NSAIDs, the choice of topical administration or oral administration likely depends on a number of factors such as age and comorbid conditions.
The objective of the study was to identify factors associated with the use of a prescription topical NSAID or a prescription oral NSAID for the treatment of sprains, strains, and contusions among patients aged 65-89 years enrolled in the Medicare Advantage with Prescription Drug plan.
The study sample was selected from the Humana Research Database (Louisville, KY, USA). Study subjects were identified as patients enrolled in Medicare Advantage with Prescription Drug plans, aged 65-89 years, having a medical claim with an International Classification of Diseases, Ninth Revision, Clinical Modification indicative of an acute sprain, strain, and contusion between 1 January, 2010 and 31 March, 2014 (identification period). The date of the first claim was considered the index date, and subjects were required to have 12 months of continuous enrollment before the index date and a minimum of 3 months continuous enrollment after the index date. Prescription NSAID use during the 3 months after the index sprain, strain, and contusion diagnosis was required for study inclusion and was identified based on a pharmacy claim for a topical or an oral NSAID. Patients with prescription NSAID use leading up to the sprains, strains, and contusions were excluded. Potential factors related to the use of a topical vs. oral NSAID were identified using stepwise logistic regression with backward elimination.
After applying the inclusion and exclusion criteria, 42,283 patients were prescribed an oral or topical NSAID (39,294 oral; 2989 topical) within 3 months of the index sprain, strain, and contusion diagnosis. After applying stepwise logistic regression, and retaining variables with statistically significant parameter estimates (p < 0.05), use of topical NSAIDs was higher among female individuals [odds ratio and 95% confidence interval = 1.34 (1.24-1.45)], and appeared to increase with age [odds ratio = 1.04 (1.04-1.05)]. Topical NSAID use was lower in the Midwest region [odds ratio = 0.85 (0.77-0.94)] in comparison to the Southern region. Clinical factors associated with topical NSAID use included Elixhauser Comorbidity Index score [odds ratio = 1.06 (1.04-1.09)], medication burden [odds ratio = 1.06 (1.04-1.08), pill burden [odds ratio = 1.02 (1.01-1.03), specific comorbid conditions, including site-specific osteoarthritis of the upper arm [odds ratio = 2.34 (1.19-4.60)], ankle/foot [odds ratio = 1.46 (1.14-1.87)], or lower leg [odds ratio = 1.21 (1.07-1.36)], myofascial pain [odds ratio = 1.31 (1.21-1.42)], gastrointestinal/hepatic disorders [odds ratio = 1.15 (1.05-1.25)], systemic/central pain [odds ratio = 1.12 (1.01-1.23)], and cataracts [odds ratio = 1.10 (1.02-1.20)]. Conversely, a diagnosis of diabetes mellitus was related to use of an oral NSAID rather than a topical NSAID [odds ratio = 0.86 (0.78-0.94)]. Diagnosis of the index sprain, strain, and contusion in an emergency department instead of a physician's office was also associated with oral NSAID use [odds ratio = 0.42 (0.37-0.47)].
Topical NSAIDs were used less often than oral NSAIDs following a sprain, strain, or contusion. Age, medication burden, pill burden, evidence of gastrointestinal disorder, and evidence of certain pain-related conditions were significant factors associated with topical NSAID as opposed to oral NSAID use. In comparison to oral NSAIDs, topical NSAIDs were more likely to be prescribed in a physician's office than an emergency department, possibly because a patient's physician has a better understanding of the patient's concomitant medications and comorbidities. Although topical NSAIDs were more likely to be used than oral NSAIDs in patients with gastrointestinal disorders, the use of oral NSAIDs among patients with gastrointestinal bleeding was substantial.
迄今为止,关于扭伤、拉伤和挫伤的研究主要集中在与运动相关的损伤、职业损伤、汽车事故导致的损伤以及需要住院治疗的严重损伤分析上。对于老年人群中实际发生的急性扭伤、拉伤和挫伤,我们了解甚少。急性扭伤、拉伤和挫伤患者可能使用非处方口服非甾体抗炎药(NSAIDs)进行治疗,也可能需要使用处方NSAIDs。对于使用处方NSAIDs治疗的扭伤、拉伤和挫伤,选择局部用药还是口服给药可能取决于多种因素,如年龄和合并症。
本研究的目的是确定在参加了医疗保险优势处方药计划的65 - 89岁患者中,与使用处方局部NSAID或处方口服NSAID治疗扭伤、拉伤和挫伤相关的因素。
研究样本选自Humana研究数据库(美国肯塔基州路易斯维尔)。研究对象被确定为参加医疗保险优势处方药计划、年龄在65 - 89岁、在2010年1月1日至2014年3月31日(识别期)期间有国际疾病分类第九版临床修订本表明急性扭伤、拉伤和挫伤的医疗索赔的患者。首次索赔日期被视为索引日期,受试者在索引日期前需连续参保12个月,索引日期后至少连续参保3个月。研究纳入标准要求在索引扭伤、拉伤和挫伤诊断后的3个月内使用处方NSAIDs,并根据局部或口服NSAIDs的药房索赔来确定。排除在扭伤、拉伤和挫伤发生前使用处方NSAIDs的患者。使用逐步逻辑回归和向后排除法确定与局部用药与口服NSAID使用相关的潜在因素。
应用纳入和排除标准后,42283例患者在索引扭伤、拉伤和挫伤诊断后的3个月内被处方口服或局部NSAIDs(39294例口服;2989例局部)。应用逐步逻辑回归并保留具有统计学显著参数估计值(p < 0.05)的变量后,女性使用局部NSAIDs的比例更高[比值比和95%置信区间 = 1.34(1.24 - 1.45)],且似乎随年龄增加而增加[比值比 = 1.04(1.04 - 1.05)]。与南部地区相比,中西部地区局部NSAIDs的使用较低[比值比 = 0.85(0.77 - 0.94)]。与局部NSAIDs使用相关的临床因素包括埃利克斯豪泽合并症指数评分[比值比 = 1.06(1.04 - 1.09)]、用药负担[比值比 = 1.06(1.04 - 1..08)]、药丸负担[比值比 = 1.02(1.01 - 1.03)]、特定合并症,包括上臂特定部位骨关节炎[比值比 = 2.34(1.19 - 4.60)]、踝/足[比值比 = 1.4.6(1.14 - 1.87)]或小腿[比值比 = 1.21(1.07 - 1.36)]、肌筋膜疼痛[比值比 = 1.31(1.21 - 1.42)]、胃肠道/肝脏疾病[比值比 = 1.15(1.05 - 1.25)]、全身性/中枢性疼痛[比值比 = 1.12(1.01 - 1.23)]和白内障[比值比 = 1.10(1.02 - 1.20)]。相反,糖尿病诊断与口服NSAIDs而非局部NSAIDs的使用相关[比值比 = 0.86(0.78 - 0.94)]。在急诊科而非医生办公室诊断索引扭伤、拉伤和挫伤也与口服NSAIDs的使用相关[比值比 = 0.42(0.37 - 0.47)]。
扭伤、拉伤或挫伤后,局部NSAIDs的使用频率低于口服NSAIDs。年龄、用药负担、药丸负担、胃肠道疾病证据以及某些疼痛相关疾病的证据是与局部NSAIDs而非口服NSAIDs使用相关的重要因素。与口服NSAIDs相比,局部NSAIDs在医生办公室比在急诊科更可能被处方,这可能是因为患者的医生对患者的伴随用药和合并症有更好的了解。尽管在胃肠道疾病患者中局部NSAIDs的使用可能比口服NSAIDs更频繁,但胃肠道出血患者中口服NSAIDs的使用也相当多。